# Efficacy and Safety of Levosimendan in Severe Acute Heart Failure in Critical Children

> **NCT01301313** · PHASE2 · TERMINATED · sponsor: **Jose Luis Vazquez Martinez** · enrollment: 116 (actual)

## Conditions studied

- Acute Heart Failure

## Interventions

- **DRUG:** Levosimendan
- **DRUG:** Conventional intensified inotropic treatment

## Key facts

- **NCT ID:** NCT01301313
- **Lead sponsor:** Jose Luis Vazquez Martinez
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-02
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2013-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01301313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01301313, "Efficacy and Safety of Levosimendan in Severe Acute Heart Failure in Critical Children". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01301313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*